Evonetix appoints Colin McCracken as chief executive officer
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect.
Source: news-medical.net